mRNA (messenger RNA), a single-stranded molecule, is the genetic coding templates used by the translational machinery. mRNA leaves the cell nucleus and moves to the cytoplasm where the translation machinery makes proteins bind to these mRNA molecules and read the code on the mRNA to make a specific protein.https://mrna.creative-biolabs.com/mrna-services.htm
Watch the presentation of this webinar here: https://bit.ly/2SWCycq
mRNA has taken center stage. Vaccines and therapeutics based on this versatile biomolecule have the potential to transform disease prevention and treatment. This webinar will explore key considerations for efficient mRNA production, starting from facility design and raw materials selection to technologies and strategies used for manufacturing.
The success of mRNA-based COVID-19 vaccines has created a significant level of interest in this versatile biomolecule for disease prevention and treatment. While production of these vaccines took place in record time, critical decisions must be made when developing novel mRNA applications to ensure manufacturability, reproducibility, and safety. This webinar will explore foundational elements of the mRNA manufacturing workflow and strategies to design the right facilities to ensure success. Topics include collaborative approaches to ensure access to high quality raw materials, application of advanced technologies for manufacturing, options for facility design and key considerations when leveraging a contract development and manufacturing partner.
In this webinar, you will learn:
• Therapeutic potential of mRNA: COVID-19 and beyond
• How mRNA manufacturing workflows and facility design have a significant impact on reproducibility and performance
• Amptec capabilities to accelerate mRNA development and manufacturing
1. The document discusses various methods for single nucleotide polymorphism (SNP) genotyping including hybridization-based methods, enzyme-based methods, and other post-amplification methods.
2. It specifically focuses on tetra-arm PCR, a method for SNP genotyping that uses allele-specific primers containing deliberate mismatches.
3. The document provides guidance on how to design tetra-arm PCR for SNP genotyping including specifying the SNP position and alleles, primer length and product size.
Original Next Gen Seq Methods set of slides prepared for Technorazz Vibes 2016. There is also a shorter version.
This starts with an introduction to qPCR followed by an introduction to Library Complexity. Microarrays are discussed as well along with a very short introduction to FISH. Finally discussion of Next gen seq methods is done where generation of sequencers are discussed and a short discussion of the ILLUMINA protocol. Finally comparison of ILLUMINA amongst other 3rd gen sequencer, description of the standard pipeline and the omics technologies that have risen from this seq data.
A biochemical technique used in Molecular Biology to amplify a specific fragment of target DNA.
PCR is used in medical and biological research, including cloning, genetic analysis, genetic fingerprinting, diagnostics, pathogen detection and genetic fingerprinting
This document discusses siRNA (small interfering RNA) technology. It defines siRNA as a class of double stranded RNA molecules typically 20-24 base pairs in length that interfere with gene expression through mRNA degradation. The document outlines the structure and function of siRNA, including its role in the RNAi pathway. Applications of siRNA technology discussed include using it as a research tool to study gene function and as a potential therapeutic agent, for example to target the ApoB gene for hypercholesterolemia or VEGF for age-related macular degeneration. Challenges to clinical use of siRNA are delivery and specificity, but it remains a promising approach for molecular medicine.
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...MilliporeSigma
Watch the webinar here: https://event.on24.com/wcc/r/2003970/F5AFA4FE6C60AD00635D4D15BADB5D8E?partnerref=slideshare
As gene therapies and gene-modified cell therapies show increasing promise, the need for innovative and proficient viral vector manufacturing continues to grow. Concurrently, increased regulatory guidance governing the manufacturing and testing of viral vectors adds complexity and increases the timelines to successfully produce high-quality virus ready for clinical use.
This webinar will address how the implementation of both manufacturing templates and platform characterization and safety assays can increase the likelihood of success in process validation and reduce risk in the timeline to commercialization for your gene therapy product. Using adeno-associated virus (AAV) as a case study, we will demonstrate how our validated, templated process for production can reduce the need for qualification inherent in niche manufacturing workflows and anticipate forthcoming needs for process performance qualification. This webinar will also highlight benefits from a new, platform assay offering for characterization and safety testing of AAV. Because these assays are pre-qualified, they reduce the variability inherent in assay validation and subsequently the time needed to establish readiness for regulatory compliance.
While these developments increase the standardization across the manufacturing and testing workflows, they remain flexible to clients' needs and are created to be scalable and as future-proof as possible, allowing for adaptability as the regulatory landscape of gene therapies evolves.
In this webinar, you will learn:
● The unit operations in AAV manufacturing that are ideal for templating
● How the manufacturing workflow can be targeted to reduce variability in testing and improve readiness for commercial production
● How platform assays can ease the burden of assay qualification and improve overall commercialization timelines
PCR is a technique which is used to amplify the number of copies of a specific region of DNA, in order to produce enough DNA to be adequately tested.
Cell-free amplification for synthesizing multiple identical copies (billions) of any DNA of interest.
Basic tool for the molecular biologist.
The purpose of a PCR is to make a huge number of copies of a gene. As a result, it now becomes possible to analyze and characterize DNA fragments found in minute quantities in places like a drop of blood at a crime scene or a cell from an extinct dinosaur.
Like Xerox machine for gene copying.
Next generation sequencing techniques have revolutionized DNA sequencing by increasing throughput and decreasing costs compared to previous methods like Sanger sequencing. Some key next generation sequencing methods include 454 sequencing (pyrosequencing), ABI Solid sequencing (sequencing by ligation), Illumina/Solexa sequencing (sequencing by synthesis), and nanopore sequencing. These new techniques allow for faster and cheaper large-scale sequencing and have enabled applications like whole genome sequencing.
Watch the presentation of this webinar here: https://bit.ly/2SWCycq
mRNA has taken center stage. Vaccines and therapeutics based on this versatile biomolecule have the potential to transform disease prevention and treatment. This webinar will explore key considerations for efficient mRNA production, starting from facility design and raw materials selection to technologies and strategies used for manufacturing.
The success of mRNA-based COVID-19 vaccines has created a significant level of interest in this versatile biomolecule for disease prevention and treatment. While production of these vaccines took place in record time, critical decisions must be made when developing novel mRNA applications to ensure manufacturability, reproducibility, and safety. This webinar will explore foundational elements of the mRNA manufacturing workflow and strategies to design the right facilities to ensure success. Topics include collaborative approaches to ensure access to high quality raw materials, application of advanced technologies for manufacturing, options for facility design and key considerations when leveraging a contract development and manufacturing partner.
In this webinar, you will learn:
• Therapeutic potential of mRNA: COVID-19 and beyond
• How mRNA manufacturing workflows and facility design have a significant impact on reproducibility and performance
• Amptec capabilities to accelerate mRNA development and manufacturing
1. The document discusses various methods for single nucleotide polymorphism (SNP) genotyping including hybridization-based methods, enzyme-based methods, and other post-amplification methods.
2. It specifically focuses on tetra-arm PCR, a method for SNP genotyping that uses allele-specific primers containing deliberate mismatches.
3. The document provides guidance on how to design tetra-arm PCR for SNP genotyping including specifying the SNP position and alleles, primer length and product size.
Original Next Gen Seq Methods set of slides prepared for Technorazz Vibes 2016. There is also a shorter version.
This starts with an introduction to qPCR followed by an introduction to Library Complexity. Microarrays are discussed as well along with a very short introduction to FISH. Finally discussion of Next gen seq methods is done where generation of sequencers are discussed and a short discussion of the ILLUMINA protocol. Finally comparison of ILLUMINA amongst other 3rd gen sequencer, description of the standard pipeline and the omics technologies that have risen from this seq data.
A biochemical technique used in Molecular Biology to amplify a specific fragment of target DNA.
PCR is used in medical and biological research, including cloning, genetic analysis, genetic fingerprinting, diagnostics, pathogen detection and genetic fingerprinting
This document discusses siRNA (small interfering RNA) technology. It defines siRNA as a class of double stranded RNA molecules typically 20-24 base pairs in length that interfere with gene expression through mRNA degradation. The document outlines the structure and function of siRNA, including its role in the RNAi pathway. Applications of siRNA technology discussed include using it as a research tool to study gene function and as a potential therapeutic agent, for example to target the ApoB gene for hypercholesterolemia or VEGF for age-related macular degeneration. Challenges to clinical use of siRNA are delivery and specificity, but it remains a promising approach for molecular medicine.
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...MilliporeSigma
Watch the webinar here: https://event.on24.com/wcc/r/2003970/F5AFA4FE6C60AD00635D4D15BADB5D8E?partnerref=slideshare
As gene therapies and gene-modified cell therapies show increasing promise, the need for innovative and proficient viral vector manufacturing continues to grow. Concurrently, increased regulatory guidance governing the manufacturing and testing of viral vectors adds complexity and increases the timelines to successfully produce high-quality virus ready for clinical use.
This webinar will address how the implementation of both manufacturing templates and platform characterization and safety assays can increase the likelihood of success in process validation and reduce risk in the timeline to commercialization for your gene therapy product. Using adeno-associated virus (AAV) as a case study, we will demonstrate how our validated, templated process for production can reduce the need for qualification inherent in niche manufacturing workflows and anticipate forthcoming needs for process performance qualification. This webinar will also highlight benefits from a new, platform assay offering for characterization and safety testing of AAV. Because these assays are pre-qualified, they reduce the variability inherent in assay validation and subsequently the time needed to establish readiness for regulatory compliance.
While these developments increase the standardization across the manufacturing and testing workflows, they remain flexible to clients' needs and are created to be scalable and as future-proof as possible, allowing for adaptability as the regulatory landscape of gene therapies evolves.
In this webinar, you will learn:
● The unit operations in AAV manufacturing that are ideal for templating
● How the manufacturing workflow can be targeted to reduce variability in testing and improve readiness for commercial production
● How platform assays can ease the burden of assay qualification and improve overall commercialization timelines
PCR is a technique which is used to amplify the number of copies of a specific region of DNA, in order to produce enough DNA to be adequately tested.
Cell-free amplification for synthesizing multiple identical copies (billions) of any DNA of interest.
Basic tool for the molecular biologist.
The purpose of a PCR is to make a huge number of copies of a gene. As a result, it now becomes possible to analyze and characterize DNA fragments found in minute quantities in places like a drop of blood at a crime scene or a cell from an extinct dinosaur.
Like Xerox machine for gene copying.
Next generation sequencing techniques have revolutionized DNA sequencing by increasing throughput and decreasing costs compared to previous methods like Sanger sequencing. Some key next generation sequencing methods include 454 sequencing (pyrosequencing), ABI Solid sequencing (sequencing by ligation), Illumina/Solexa sequencing (sequencing by synthesis), and nanopore sequencing. These new techniques allow for faster and cheaper large-scale sequencing and have enabled applications like whole genome sequencing.
PCR, RT-PCR, and real-time PCR are techniques used to amplify specific DNA or RNA sequences. PCR uses DNA polymerase to amplify a targeted DNA segment through repeated heating and cooling cycles. RT-PCR first uses reverse transcriptase to convert RNA to cDNA, then amplifies the cDNA using PCR. Real-time PCR detects amplification as it occurs through the use of fluorescence, allowing for quantitative analysis of DNA or cDNA amounts in real time. These techniques have applications in research, disease diagnosis, forensics, and more.
The document discusses polymerase chain reaction (PCR), including its history, components, principles, and applications. PCR is a technique that amplifies a specific DNA sequence, allowing small amounts to be used for testing. It involves cycling between heating and cooling steps to denature and extend DNA. Key components are DNA template, primers, DNA polymerase, magnesium, and dNTPs. Applications include pathogen detection, genetic analysis, forensics, and more. PCR is a powerful tool in research and clinical settings.
This is a presentation slide about cellular RNA interference process and RNA interference technology. Contains basic information about biology of cellular RNA interference processes and its discovery, and RNA interference technology. Also gives you the history and development of in-vitro and in-vivo technologies for applicability of RNA interference technology.
siRNA synthesis, siRNA libraries, siRNA delivering techniques, Electroporation, viral transfection methods, Advantages and disadvantages of RNA interference technology.
details about the preliminary and pre-clinical experiments of RNA interference as well as clinical trials of RNA interference.
This document discusses several types of PCR techniques and their applications. It begins by explaining standard PCR and its development. It then describes several specialized PCR techniques including allele-specific PCR, asymmetric PCR, assembly PCR, hot-start PCR, helicase-dependent amplification, in situ PCR, inverse PCR, ligation-mediated PCR, and multiplex ligation-dependent probe amplification. Each technique is explained and examples of its uses and applications are provided.
Single nucleotide polymorphisms (sn ps), haplotypes,Karan Veer Singh
This document provides an overview of SNPs (single nucleotide polymorphisms), including their biological background, terminology, detection techniques, and applications. It defines SNPs as single base changes that occur in at least 1% of a population. SNPs can be harmless, harmful, or latent, and are found primarily in noncoding regions, occurring around every 100-300 bases. The document discusses techniques for detecting known and unknown SNPs, including hybridization methods like microarrays and PCR, as well as enzyme-based techniques like nucleotide extension, cleavage, and ligation. It notes applications of SNPs in areas like gene discovery, disease association studies, diagnostics, and predicting treatment response.
Genomics research and discovery has led to a large increase of reported single nucleotide polymorphisms (SNPs). From 2006 to 2017, the number of refSNPs in the NCBI dbSNP database has increased 13-fold. Many polymorphisms can be linked to disease susceptibility and responses to chemical therapies. Other polymorphisms are used as trait identifiers in livestock and plants. Being able to inexpensively and accurately determine the genotype in high-throughput fashion, with low sample input is a critical need in current, large-scale screening efforts. In this presentation, we present a novel, probe-based, PCR genotyping solution that possesses the universal cycling conditions, strong signal generation, and benchtop reaction stability needed for high-throughput screening. We also present the mechanism and unique technical advantages of using the rhAmp SNP Genotyping System, and we will illustrate how easy it is to generate high quality genotyping data.
CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that have previously infected the prokaryote and are used to detect and destroy DNA from similar phages during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.
Cas9 (CRISPR-associated protein 9) is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms.This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.
The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages that provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA. Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
This document discusses PCR primer design. It defines a primer as a short synthetic oligonucleotide used in molecular techniques to anneal to a region of template DNA. Key considerations for primer design include length of 18-24 bases, GC content of 40-60%, melting temperature between 50-60°C, and no complementarity between primer pairs or within individual primers. Several online tools for primer design are also mentioned, including Primer Blast, Primer3, NetPrimer, DNAMate, and The PCR Suite. References on the topic are provided at the end.
The document discusses the history and development of the polymerase chain reaction (PCR) technique. It describes how Kary Mullis invented PCR in 1985 and was awarded the Nobel Prize for it. It then explains the basic steps of PCR including denaturation, annealing of primers, and extension. Finally, it discusses several variations and applications of PCR including real-time PCR, asymmetric PCR, and comparisons to cloning techniques.
PCR (polymerase chain reaction) was invented in 1987 by Kary Mullis to specifically amplify a single DNA sequence. It takes advantage of DNA replication by using DNA polymerase, primers, and thermocycling to exponentially amplify the target sequence. PCR is now widely used in applications such as cloning, forensics, disease detection, and more due to its ability to amplify small amounts of DNA.
This document provides an overview of CRISPR-Cas9 technology. It defines CRISPR as DNA sequences in bacteria that contain snippets of viral DNA used to detect and destroy invading viruses. The CRISPR system contains Cas9 proteins that cut DNA at specific locations guided by RNA, and RNA guide molecules. It works by integrating viral DNA into the bacteria's CRISPR loci, which are then transcribed into RNA to guide Cas9 to cleave invading viral DNA. Applications of CRISPR include disease modeling, cancer research, and correcting mutations in human embryos.
The above presentation consist of the definition of microarray, brief history, general principle of the same, the type of scanner that are used to read or to scan the microarray , type of DNA microarray and finally its various apliccation including the role of DNA microaarray in drug discovery.
Unlocking the Potential of mRNA Vaccines and TherapeuticsMerck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/3lNmkf7
The therapeutic potential of mRNA has been studied for decades and this exciting modality could potentially disrupt the biological market, in particular vaccine and novel therapies. This webinar will highlight the potential of mRNA therapies and focus on the manufacturing process's associated challenges, solutions and perspectives from synthesis to delivery.
mRNA has emerged as a promising modality for a wide range of therapeutics and vaccines and could become the break-through technology of this century. mRNA-based platform technologies could enable a more rapid response to infectious diseases, outbreaks or pandemics and allow efficient gene replacements or cancer treatments. mRNA represents a safer alternative to DNA-based therapies and the technology has recently advanced to overcome stability and efficacy challenges. Because of that, the industrialization of this technology is just in its infancy stages and bottlenecks exist around scalability, purity, and delivery which are key to establish and deliver the promise of such platform. This webinar will shed light on the potential of mRNA therapies and focus on the manufacturing process's associated challenges, solutions and perspectives from synthesis to delivery.
In this webinar, you will learn:
• The potential behind using mRNA as a therapeutic and vaccine
• The mRNA production process
• The challenges around mRNA production
• The solutions and perspectives for a robust manufacturing process
• mRNA delivery systems and their manufacturing
This document describes RT-PCR (reverse transcription polymerase chain reaction). It discusses that RT-PCR is used to detect RNA expression by converting RNA to cDNA using reverse transcriptase, then amplifying the cDNA using PCR. It provides details on the history and development of RT-PCR, including the discovery of reverse transcriptase. It also explains the basic procedures for one-step and two-step RT-PCR and compares the two methods.
High throughput next generation sequencing and robust transcriptome analysis help with gene expression profiling, gene annotation or discovery of non-coding RNA.
This document summarizes Shivendra Kumar's class presentation on SNP genotyping using KASP. It introduces SNP genotyping and the KASP platform. It describes using KASP to genotype a wheat mapping population derived from a cross between an introgression line containing stripe rust resistance genes and a susceptible cultivar. KASP markers were developed and used to map the resistance genes. One candidate resistance gene was identified and further analyzed through expression studies and development of a linked KASP marker. Recombinants were identified and confirmed through additional KASP genotyping.
complete Single Nucleotide Polymorphiitsm Detection methods with Advance techniques with its applications
Single nucleotide polymorphisms are single base variations between genomes within a species.
There are at least 10 million polymorphic sites in the human genome.
SNPs can distinguish individuals from one another
Denaturing Gradient Gel Electrophoresis
Chemical Cleavage Of Mismatch
Single-stranded Conformation Polymorphism (SSCP)
MutS Protein-binding Assays
Mismatch Repair Detection (MRD)
Heteroduplex Analysis (HA)
Denaturing High Performance Liquid Chromatography (DHPLC)
UNG-Mediated T-Sequencing
RNA-Mediated Finger printing with MALDI MS Detection
Sequencing by Hybridization
Direct DNA Sequencing
Single-feature polymorphism (SFP)
Invader probe
Allele-specific oligonucleotide probes
PCR-based methods
Allele specific primers
Sequence Polymorphism-Derived (SPD) markers
Targeting induced local lesions in genomes (TILLinG)
Minisequencing primers
Allele-specific ligation probes
Mass Spectrometry: Protein Identification StrategiesMichel Dumontier
The document discusses protein identification strategies using mass spectrometry, including peptide mass fingerprinting (PMF) and tandem mass spectrometry. PMF involves comparing observed peptide masses from an unknown protein to theoretical masses in a database to identify matches, while tandem mass spectrometry fragments peptides and matches the fragmentation pattern to sequences in the database. The document provides details on how each technique works and their relative advantages and limitations.
Deciphering DNA sequences is essential for virtually all branches of biological research. With the
advent of capillary electrophoresis (CE)-based Sanger sequencing, scientists gained the ability to
elucidate genetic information from any given biological system. This technology has become widely
adopted in laboratories around the world, yet has always been hampered by inherent limitations in
throughput, scalability, speed, and resolution that often preclude scientists from obtaining the essential
information they need for their course of study. To overcome these barriers, an entirely new technology
was required—Next-Generation Sequencing (NGS), a fundamentally different approach to sequencing
that triggered numerous ground-breaking discoveries and ignited a revolution in genomic science.
Antisense oligonucleotide therapy is a pharmacological approach that uses synthetic genetic material to inhibit protein translation by binding to mRNA. It works by blocking ribosomes, activating RNase enzymes, or forming triplex structures. Advantages include rapid manufacturing and potential for enhanced targeting. Limitations include short half-lives and difficulty directing to specific cells. Over 50 antisense compounds are in clinical trials for various diseases. The future of antisense-based therapies looks promising as more companies develop applications.
Creative Biolabs provides custom mRNA synthesis services using either chemical synthesis or in vitro transcription. Chemical synthesis is recommended for fragments under 140 bp as it is quicker and more economical. In vitro transcription is recommended for longer fragments up to thousands of bases as yield decreases exponentially with increasing length for chemical synthesis. Creative Biolabs can recommend the best approach and provide end-to-end services from plasmid preparation to purification and quality control.
Creative Biolabs provides mRNA synthesis services including primer design and synthesis for amplifying specific RNA sequences. They perform quality control on mRNA products through a variety of tests to verify identity, length, content, purity, integrity, and absence of contaminants. Creative Biolabs can customize quality control services to meet specific requirements and help expedite mRNA research.
PCR, RT-PCR, and real-time PCR are techniques used to amplify specific DNA or RNA sequences. PCR uses DNA polymerase to amplify a targeted DNA segment through repeated heating and cooling cycles. RT-PCR first uses reverse transcriptase to convert RNA to cDNA, then amplifies the cDNA using PCR. Real-time PCR detects amplification as it occurs through the use of fluorescence, allowing for quantitative analysis of DNA or cDNA amounts in real time. These techniques have applications in research, disease diagnosis, forensics, and more.
The document discusses polymerase chain reaction (PCR), including its history, components, principles, and applications. PCR is a technique that amplifies a specific DNA sequence, allowing small amounts to be used for testing. It involves cycling between heating and cooling steps to denature and extend DNA. Key components are DNA template, primers, DNA polymerase, magnesium, and dNTPs. Applications include pathogen detection, genetic analysis, forensics, and more. PCR is a powerful tool in research and clinical settings.
This is a presentation slide about cellular RNA interference process and RNA interference technology. Contains basic information about biology of cellular RNA interference processes and its discovery, and RNA interference technology. Also gives you the history and development of in-vitro and in-vivo technologies for applicability of RNA interference technology.
siRNA synthesis, siRNA libraries, siRNA delivering techniques, Electroporation, viral transfection methods, Advantages and disadvantages of RNA interference technology.
details about the preliminary and pre-clinical experiments of RNA interference as well as clinical trials of RNA interference.
This document discusses several types of PCR techniques and their applications. It begins by explaining standard PCR and its development. It then describes several specialized PCR techniques including allele-specific PCR, asymmetric PCR, assembly PCR, hot-start PCR, helicase-dependent amplification, in situ PCR, inverse PCR, ligation-mediated PCR, and multiplex ligation-dependent probe amplification. Each technique is explained and examples of its uses and applications are provided.
Single nucleotide polymorphisms (sn ps), haplotypes,Karan Veer Singh
This document provides an overview of SNPs (single nucleotide polymorphisms), including their biological background, terminology, detection techniques, and applications. It defines SNPs as single base changes that occur in at least 1% of a population. SNPs can be harmless, harmful, or latent, and are found primarily in noncoding regions, occurring around every 100-300 bases. The document discusses techniques for detecting known and unknown SNPs, including hybridization methods like microarrays and PCR, as well as enzyme-based techniques like nucleotide extension, cleavage, and ligation. It notes applications of SNPs in areas like gene discovery, disease association studies, diagnostics, and predicting treatment response.
Genomics research and discovery has led to a large increase of reported single nucleotide polymorphisms (SNPs). From 2006 to 2017, the number of refSNPs in the NCBI dbSNP database has increased 13-fold. Many polymorphisms can be linked to disease susceptibility and responses to chemical therapies. Other polymorphisms are used as trait identifiers in livestock and plants. Being able to inexpensively and accurately determine the genotype in high-throughput fashion, with low sample input is a critical need in current, large-scale screening efforts. In this presentation, we present a novel, probe-based, PCR genotyping solution that possesses the universal cycling conditions, strong signal generation, and benchtop reaction stability needed for high-throughput screening. We also present the mechanism and unique technical advantages of using the rhAmp SNP Genotyping System, and we will illustrate how easy it is to generate high quality genotyping data.
CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that have previously infected the prokaryote and are used to detect and destroy DNA from similar phages during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.
Cas9 (CRISPR-associated protein 9) is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms.This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.
The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages that provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA. Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
This document discusses PCR primer design. It defines a primer as a short synthetic oligonucleotide used in molecular techniques to anneal to a region of template DNA. Key considerations for primer design include length of 18-24 bases, GC content of 40-60%, melting temperature between 50-60°C, and no complementarity between primer pairs or within individual primers. Several online tools for primer design are also mentioned, including Primer Blast, Primer3, NetPrimer, DNAMate, and The PCR Suite. References on the topic are provided at the end.
The document discusses the history and development of the polymerase chain reaction (PCR) technique. It describes how Kary Mullis invented PCR in 1985 and was awarded the Nobel Prize for it. It then explains the basic steps of PCR including denaturation, annealing of primers, and extension. Finally, it discusses several variations and applications of PCR including real-time PCR, asymmetric PCR, and comparisons to cloning techniques.
PCR (polymerase chain reaction) was invented in 1987 by Kary Mullis to specifically amplify a single DNA sequence. It takes advantage of DNA replication by using DNA polymerase, primers, and thermocycling to exponentially amplify the target sequence. PCR is now widely used in applications such as cloning, forensics, disease detection, and more due to its ability to amplify small amounts of DNA.
This document provides an overview of CRISPR-Cas9 technology. It defines CRISPR as DNA sequences in bacteria that contain snippets of viral DNA used to detect and destroy invading viruses. The CRISPR system contains Cas9 proteins that cut DNA at specific locations guided by RNA, and RNA guide molecules. It works by integrating viral DNA into the bacteria's CRISPR loci, which are then transcribed into RNA to guide Cas9 to cleave invading viral DNA. Applications of CRISPR include disease modeling, cancer research, and correcting mutations in human embryos.
The above presentation consist of the definition of microarray, brief history, general principle of the same, the type of scanner that are used to read or to scan the microarray , type of DNA microarray and finally its various apliccation including the role of DNA microaarray in drug discovery.
Unlocking the Potential of mRNA Vaccines and TherapeuticsMerck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/3lNmkf7
The therapeutic potential of mRNA has been studied for decades and this exciting modality could potentially disrupt the biological market, in particular vaccine and novel therapies. This webinar will highlight the potential of mRNA therapies and focus on the manufacturing process's associated challenges, solutions and perspectives from synthesis to delivery.
mRNA has emerged as a promising modality for a wide range of therapeutics and vaccines and could become the break-through technology of this century. mRNA-based platform technologies could enable a more rapid response to infectious diseases, outbreaks or pandemics and allow efficient gene replacements or cancer treatments. mRNA represents a safer alternative to DNA-based therapies and the technology has recently advanced to overcome stability and efficacy challenges. Because of that, the industrialization of this technology is just in its infancy stages and bottlenecks exist around scalability, purity, and delivery which are key to establish and deliver the promise of such platform. This webinar will shed light on the potential of mRNA therapies and focus on the manufacturing process's associated challenges, solutions and perspectives from synthesis to delivery.
In this webinar, you will learn:
• The potential behind using mRNA as a therapeutic and vaccine
• The mRNA production process
• The challenges around mRNA production
• The solutions and perspectives for a robust manufacturing process
• mRNA delivery systems and their manufacturing
This document describes RT-PCR (reverse transcription polymerase chain reaction). It discusses that RT-PCR is used to detect RNA expression by converting RNA to cDNA using reverse transcriptase, then amplifying the cDNA using PCR. It provides details on the history and development of RT-PCR, including the discovery of reverse transcriptase. It also explains the basic procedures for one-step and two-step RT-PCR and compares the two methods.
High throughput next generation sequencing and robust transcriptome analysis help with gene expression profiling, gene annotation or discovery of non-coding RNA.
This document summarizes Shivendra Kumar's class presentation on SNP genotyping using KASP. It introduces SNP genotyping and the KASP platform. It describes using KASP to genotype a wheat mapping population derived from a cross between an introgression line containing stripe rust resistance genes and a susceptible cultivar. KASP markers were developed and used to map the resistance genes. One candidate resistance gene was identified and further analyzed through expression studies and development of a linked KASP marker. Recombinants were identified and confirmed through additional KASP genotyping.
complete Single Nucleotide Polymorphiitsm Detection methods with Advance techniques with its applications
Single nucleotide polymorphisms are single base variations between genomes within a species.
There are at least 10 million polymorphic sites in the human genome.
SNPs can distinguish individuals from one another
Denaturing Gradient Gel Electrophoresis
Chemical Cleavage Of Mismatch
Single-stranded Conformation Polymorphism (SSCP)
MutS Protein-binding Assays
Mismatch Repair Detection (MRD)
Heteroduplex Analysis (HA)
Denaturing High Performance Liquid Chromatography (DHPLC)
UNG-Mediated T-Sequencing
RNA-Mediated Finger printing with MALDI MS Detection
Sequencing by Hybridization
Direct DNA Sequencing
Single-feature polymorphism (SFP)
Invader probe
Allele-specific oligonucleotide probes
PCR-based methods
Allele specific primers
Sequence Polymorphism-Derived (SPD) markers
Targeting induced local lesions in genomes (TILLinG)
Minisequencing primers
Allele-specific ligation probes
Mass Spectrometry: Protein Identification StrategiesMichel Dumontier
The document discusses protein identification strategies using mass spectrometry, including peptide mass fingerprinting (PMF) and tandem mass spectrometry. PMF involves comparing observed peptide masses from an unknown protein to theoretical masses in a database to identify matches, while tandem mass spectrometry fragments peptides and matches the fragmentation pattern to sequences in the database. The document provides details on how each technique works and their relative advantages and limitations.
Deciphering DNA sequences is essential for virtually all branches of biological research. With the
advent of capillary electrophoresis (CE)-based Sanger sequencing, scientists gained the ability to
elucidate genetic information from any given biological system. This technology has become widely
adopted in laboratories around the world, yet has always been hampered by inherent limitations in
throughput, scalability, speed, and resolution that often preclude scientists from obtaining the essential
information they need for their course of study. To overcome these barriers, an entirely new technology
was required—Next-Generation Sequencing (NGS), a fundamentally different approach to sequencing
that triggered numerous ground-breaking discoveries and ignited a revolution in genomic science.
Antisense oligonucleotide therapy is a pharmacological approach that uses synthetic genetic material to inhibit protein translation by binding to mRNA. It works by blocking ribosomes, activating RNase enzymes, or forming triplex structures. Advantages include rapid manufacturing and potential for enhanced targeting. Limitations include short half-lives and difficulty directing to specific cells. Over 50 antisense compounds are in clinical trials for various diseases. The future of antisense-based therapies looks promising as more companies develop applications.
Creative Biolabs provides custom mRNA synthesis services using either chemical synthesis or in vitro transcription. Chemical synthesis is recommended for fragments under 140 bp as it is quicker and more economical. In vitro transcription is recommended for longer fragments up to thousands of bases as yield decreases exponentially with increasing length for chemical synthesis. Creative Biolabs can recommend the best approach and provide end-to-end services from plasmid preparation to purification and quality control.
Creative Biolabs provides mRNA synthesis services including primer design and synthesis for amplifying specific RNA sequences. They perform quality control on mRNA products through a variety of tests to verify identity, length, content, purity, integrity, and absence of contaminants. Creative Biolabs can customize quality control services to meet specific requirements and help expedite mRNA research.
The QIAGEN Service Core provides a full service for genomic and expression analysis using cutting-edge tools. It accepts various sample types and performs experiments, such as pathway-focused analysis, whole genome analysis, and real-time PCR, using reagents and equipment. This allows customers to save costs by avoiding investing in their own resources and saves time by outsourcing experimental work. A variety of nucleic acid and data analysis services are available.
Technical Guide to Qiagen PCR Arrays - Download the GuideQIAGEN
Total RNA discovery with RT2 and miScript PCR Arrays : Explore the RNA universe - Whatever your destination within the RNA universe, QIAGEN will help you get there. The miRNeasy kits deliver pure, high-quality total RNA from a broad range of samples. The RT2 and miScript PCR arrays are a complete solution both for focused analysis of gene and microRNA expression and for validation of microarray and RNA sequencing experiments. Together with the powerful analytics tools of GeneGlobe® and QIAGEN Ingenuity® Pathway Analysis, these products give you a smooth path from your sample to high-quality results.
The document describes miScript miRNA PCR Arrays for analyzing miRNA expression patterns. It discusses miRNA biogenesis and function, and how the miScript system allows for genome-wide and pathway-focused miRNA analysis using a qPCR-based approach. The miScript arrays offer high reproducibility, sensitivity, and the ability to discover cancer-related and developmentally regulated miRNAs. They can be used to screen focused miRNA panels or conduct genome-wide screens to discover novel miRNA roles.
Reporter assay and q pcr application 2012Elsa von Licy
This document summarizes a presentation on high-performance cell-based assay and qPCR technologies for pathway-focused research. The presentation overview discusses QIAGEN's SABiosciences portfolio, PCR arrays, Cignal and Cignal Lenti pathway reporters, and provides a summary. PCR arrays allow analysis of mRNA expression of up to 84 genes related to biological pathways in a single experiment. Cignal reporter assays use dual-luciferase reporters to study 45 signal transduction pathways. Cignal Lenti reporters use lentiviral delivery of luciferase or GFP reporters to study pathways in difficult to transfect cells like stem cells or primary cells.
The document discusses BioChain's products for PCR and sample preparation, including PCR enzymes, reverse transcriptases, master mixes, dNTPs, and supporting reagents. It provides details on BioChain's Taq DNA polymerase and Hot Start Taq DNA polymerase, which are produced under strict quality control. It also describes BioChain's UltraScript reverse transcriptase, which is ideal for cDNA synthesis of templates with secondary structure or high GC content. Furthermore, it mentions BioChain's pre-mixed master mixes for standard and quantitative PCR, which offer convenience and reproducibility.
TriMix is a mixture of three types of mRNAs, which are responsible for encoding several immune-stimulating factors, such as CD40L, CD70, as well as TLR4. TLR4 stimulates DCs to present different types of antigens to CD4/CD8 T cells, CD40L induces CD4 T cells to initiate antigen-specific cell immunity, and CD70 induces CD8 T cell immune responses.https://mrna.creative-biolabs.com/trimix-technology.htm
Transposagen Genome Engineering Brochure 2014Dustin Perry
Transposagen Biopharmaceuticals is a leading company in genome engineering technologies and services. They offer various gene editing tools including NextGEN CRISPR, XTNTM TALENs, and piggyBac transposon system. Their piggyBac system allows for footprint-free gene editing which can precisely edit genes without unwanted changes. They provide custom gene editing reagents and services for applications such as bioproduction, therapeutics, disease models, and more.
This document describes miScript miRNA PCR Arrays, which allow for the simultaneous detection of genome-wide or pathway-focused microRNA (miRNA) expression. It provides an overview of miRNA biology and research, details the miScript miRNA PCR Array system workflow from isolation to data analysis, and discusses applications in cancer research, development, differentiation, and genome-wide discovery. The system offers validated miRNA assays, controls, and optimized reagents to enable reproducible and reliable miRNA expression profiling from RNA samples.
This document discusses how microarrays and RNA sequencing (RNA-Seq) are complementary approaches for genomics research. It notes that while RNA-Seq is useful for discovering unknown transcripts, microarrays allow researchers to quickly and cost-effectively profile known pathways and genes. The document also highlights how microarrays can generate data from limited or degraded RNA samples not amenable to RNA-Seq, and can validate potential RNA-Seq hits simultaneously. It concludes by emphasizing the robust, cost-effective, and proven nature of microarray technology as a complement to emerging NGS approaches.
This document discusses new assays for microRNA (miRNA) research, including isolation, expression analysis, and functional analysis. It describes miRNA isolation kits that can purify miRNAs from various sample types. For expression analysis, it highlights real-time PCR-based miRNA assays, including miRNA PCR arrays that can profile hundreds of miRNAs simultaneously. It also discusses tools for identifying miRNA targets and analyzing miRNA function, such as miRNA mimics and inhibitors. Examples are given of how these assays have been used to study miRNAs in cancer and other diseases.
a full range of complement therapeutic services and complement based drug discovery services for customers at https://www.creative-biolabs.com/complement-therapeutics/
The document describes miScript miRNA PCR Arrays, which enable comprehensive profiling of miRNAs for disease research and biomarker discovery. The arrays contain extensively verified assays for miRNAs related to biological pathways and diseases. The miScript PCR system provides sensitive and reproducible quantification of miRNA expression. It allows isolation of miRNA from samples, conversion to cDNA, and real-time PCR profiling of miRNA expression across pathway- or disease-focused arrays.
The document describes miScript miRNA PCR Arrays, which enable comprehensive profiling of miRNAs for disease research and biomarker discovery. The arrays use a validated PCR technique to quantify miRNA expression levels from tissue samples. They are available in customizable panels focused on specific biological pathways, diseases, or the entire miRNome. The workflow involves isolating miRNA from samples, converting it to cDNA, and running real-time PCR on the array to obtain expression data for targeted miRNAs. The technique provides sensitive and reproducible miRNA profiling to explore their roles in biological contexts and diseases.
This document discusses in silico PCR, which is a computational technique for simulating PCR reactions without physically performing experiments in a lab. It allows researchers to predict amplicon size and location, and assess primer specificity. The key benefits of in silico PCR include cost-efficiency, time savings, experimental design assistance, and quality control. The document provides details on the protocol for conducting in silico PCR using various bioinformatics tools. It also outlines some common applications of PCR such as DNA amplification, molecular cloning, and gene expression analysis.
Meeting the challenges of miRNA research: miRNA and its Role in Human Disease...QIAGEN
This document discusses a 4-part webinar series on microRNA (miRNA) research presented by QIAGEN. Part 1 will cover miRNA profiling from biofluids, part 2 will discuss challenges in miRNA research, part 3 will focus on advanced miRNA expression analysis, and part 4 will analyze functional analysis of miRNA. The document provides background on miRNAs and their role in gene expression and disease. It also describes QIAGEN products and solutions for miRNA sample preparation, real-time PCR, data analysis, and functional validation to help researchers overcome challenges in miRNA analysis.
This document describes Norgen Biotek Corporation, a company that provides sample preparation kits for RNA, microRNA, DNA and protein purification from various sample types. It offers over 40 kits for total RNA isolation without the use of phenol, including kits for cultured cells, tissues, blood, and formalin-fixed paraffin-embedded samples. The document highlights that Norgen's kits recover a full size range of RNA, including small RNA and microRNA, and provide high quality RNA suitable for various downstream applications. It also provides contact information, ordering details, and an overview of Norgen's RNA purification kits and their applications.
This document discusses RNA interference and provides information about QIAGEN's SureSilencing shRNA plasmids for gene knockdown experiments. It begins with an introduction to RNAi mechanisms and challenges. It then describes QIAGEN's SureSilencing shRNA plasmid solution, which features guaranteed high knockdown efficiency, multiple designs to control off-target effects, and experimental validation. The document reviews the plasmid features, design algorithm, applications and provides a workflow for gene knockdown experiments using the plasmids. It emphasizes the importance of including appropriate controls and validation steps to ensure successful RNAi experiments.
Recently, the development of molecular biotechnology allows modifications of viral genomes genetically and optimizes the transformation of available viruses with weak pathogenicity. These methods are used to enhance the oncolytic effect and reduce adverse reactions to maximize both efficacy and safety. Indeed, the oncolytic virus can stimulate a pro-inflammatory tumor environment by enhancing antigen recognition and robust immune responses. It overcomes the immune evasiveness and escape of malignant cells to eliminate the tumor cells.
https://www.creative-biolabs.com/oncolytic-virus/definition-of-an-oncolytic-virus.htm
An oncolytic virus is a form of promising therapeutic tool for the treatment of malignant tumors, which uses viruses to selectively infect and kill tumor cells and further to induce or boost specific antitumor immunity. https://www.creative-biolabs.com/oncolytic-virus/definition-of-an-oncolytic-virus.htm
Oncolytic viruses encoding reporter genes utilized for in vivo molecular imaging are useful to locate the distribution of oncolytic viruses in pre-clinical tests. Optical detection methods mainly include green fluorescent protein (GFP), enhanced GFP (eGFP), discosoma red fluorescent protein (DsRed), and bioluminescence imaging (BLI), which utilizes luciferases. Reporter-encoding oncolytic viruses, including vaccinia virus, adenovirus, herpes simplex virus and vesicular stomatitis virus, allow accurate tracking of gene expression, tumor metastases, viral infection as well as assessment of gene therapy.
https://www.creative-biolabs.com/oncolytic-virus/category-reporter-encoding-oncolytic-virus-293.htm
Vaccinia virus can accommodate more than 30 kb of foreign DNA. Foreign genes can be stably integrated into the viral genome, resulting in efficient and long-term gene expression. The deletion of the viral genes of thymidine kinase (TK) and vaccinia growth factors (VGF) results in enhanced tumor-selectively and antitumor activity, and reduced virus virulence. https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-vaccinia-virus-291.htm
Oncolytic viruses are a class of antitumor agents that selectively kill tumor cells without affecting normal cells. Vaccinia virus (VACV) is a large, enveloped virus that is considered as the most potential live biotherapeutic agent because of its strong oncolytic efficacy and potent antigen presentation capability that can combine well with its natural oncolytic activities for cancer immunotherapy. Many types of modified vaccinia virus have been used for in vitro and in vivo studies, as well as clinical trials.https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-vaccinia-virus-291.htm
Partial deletion of the HSV gene results in superior packaging capacity of >30 kb foreign DNA with low toxicity as an expression vector. Multiple modified purified oncolytic herpes simplex virus (oHSV) products can avoid evading the host immune response and reduce toxicity by gene knock-out, such as ICP0, ICP4, ICP22, ICP27 or ICP47.https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-herpes-simplex-virus-290.htm
Oncolytic viruses are using for the treatment of cancer due to the specific antitumor activity in tumor cells. Herpes simplex virus (HSV) is a human neurogenic dsDNA virus that has the characteristic of life-long latent infection of neurons and allows for long-term transgene expression.https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-herpes-simplex-virus-290.htm
Oncolytic viruses have the potential to powerfully and selectively kill cancer cells and have shown impressive efficacy in preclinical and clinical settings. However, their potential can be restricted by inefficient delivery into the complex tumor environment. Thus, the efficient delivery of oncolytic viruses remains a significant challenge in the field of oncology, limiting their therapeutic effect. https://www.creative-biolabs.com/oncolytic-virus/approaches-to-delivery-of-oncolytic-viruses.htm
Numerous viruses are being developed pre-clinically and clinically. An investigation of all registered clinical trials in 2017 demonstrates 78 interventional trials regarding OVs. This ability for near-universal therapeutic impact in cancer makes OVs a popular therapeutic tool. Today, both preclinical and early-stage clinical trials are intensively investigating the approach to improve oncolytic virotherapy.
https://www.creative-biolabs.com/oncolytic-virus/applications-of-oncolytic-viruses-in-cancer-treatment.htm
To fully optimize oncolytic virotherapy and provide meaningful mechanistic insight, it is important to have representative animal models of oncolysis in various tumor types. https://www.creative-biolabs.com/oncolytic-virus/animal-models-for-oncolytic-virus-study.htm
Abciximab (also known as abcixifiban or c7E3 Fab), is the Fab fragment of the chimeric human-murine, monoclonal antibody 7E3. It is composed of murine variable regions and human constant regions.https://www.creativebiolabs.net/abciximab-overview.htm
Abagovomab is a murine monoclonal anti-idiotypic antibody (MW: 165-175 kDa), produced by a mouse hybridoma and generated against OC125, which serves to functionally imitate the human cancer antigen 125 (CA-125). https://www.creativebiolabs.net/abagovomab-overview.htm
Wnt comprises a diverse family of secreted lipid-modified signaling glycoproteins that are 350-400 amino acids in length. Wnt is an acronym in the field of genetics that stands for 'Wingless/Integrated'.https://www.creativebiolabs.net/wnt-signaling-pathway.htm
TNF works through two receptors, TNFR1 and TNFR2. TNFR1 is the major signal receptor of TNF-α. TNFR2, which mediates limited biological responses, binds to TNF-α and TNF-β. TNF signaling transduction through TNFR1 and TNFR2 can induce a variety of cellular responses, which depends on many factors, including the metabolic state of the cell and the adaptor proteins present in the cell.https://www.creativebiolabs.net/tnf-signaling-pathway.htm
Innate immune receptors, also known as pattern recognition receptors (PRRs), have been identified in the serum, on the cell surface, in endosomes, and in the cytoplasm. Toll-like receptors (TLRs) is one of the particularly important groups of PRRs.https://www.creativebiolabs.net/tlr-signal-pathway.htm
Transforming growth factor beta (TGF-β) is a cytokine that participates in both physiological and pathological processes.https://www.creativebiolabs.net/tgf-beta-signaling-pathway.htm
T-cell receptor (TCR) is a heterodimers composed of α and β peptide chains. TCR is mainly responsible for recognizing the antigens presented by major histocompatibility complex (MHC) molecules on the surface of antigen presenting cells (APC).https://www.creativebiolabs.net/tcr-signal-pathway.htm
Ras, which is a low-molecular-weight GDP/GTP-binding guanine triphosphatase, is the prototypical member of the Ras superfamily of proteins. https://www.creativebiolabs.net/ras-signaling-pathway.htm
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors, which are responsible for regulating gene expression.https://www.creativebiolabs.net/ppar-signaling-pathway.htm
PI3K-Akt signaling pathway is one of the important signal transduction pathways in cells. It is involved in regulating cell metabolism, growth, proliferation, survival, transcription and protein synthesis by affecting the activation of downstream effector molecules. https://www.creativebiolabs.net/pi3k-akt-signaling-pathway.htm
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills MN
Travis Hills of Minnesota developed a method to convert waste into high-value dry fertilizer, significantly enriching soil quality. By providing farmers with a valuable resource derived from waste, Travis Hills helps enhance farm profitability while promoting environmental stewardship. Travis Hills' sustainable practices lead to cost savings and increased revenue for farmers by improving resource efficiency and reducing waste.
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...University of Maribor
Slides from talk:
Aleš Zamuda: Remote Sensing and Computational, Evolutionary, Supercomputing, and Intelligent Systems.
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Inter-Society Networking Panel GRSS/MTT-S/CIS Panel Session: Promoting Connection and Cooperation
https://www.etran.rs/2024/en/home-english/
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
ESPP presentation to EU Waste Water Network, 4th June 2024 “EU policies driving nutrient removal and recycling
and the revised UWWTD (Urban Waste Water Treatment Directive)”
hematic appreciation test is a psychological assessment tool used to measure an individual's appreciation and understanding of specific themes or topics. This test helps to evaluate an individual's ability to connect different ideas and concepts within a given theme, as well as their overall comprehension and interpretation skills. The results of the test can provide valuable insights into an individual's cognitive abilities, creativity, and critical thinking skills
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxRASHMI M G
Abnormal or anomalous secondary growth in plants. It defines secondary growth as an increase in plant girth due to vascular cambium or cork cambium. Anomalous secondary growth does not follow the normal pattern of a single vascular cambium producing xylem internally and phloem externally.
1. State-of-art Technology
Platforms ·Available in Flexible
Scales ·High-quality & Customized
Services ·Cost-saving
World’s Leading Provider for mRNA
Products & Services
mRNA Platform
Make High Quality mRNA
Supporting
2. About Creative Biolabs
mRNA Services
Areas of Expertise Our mRNA Services
Custom mRNA synthesis
Custom mRNA modification
Custom delivery vehicle for mRNA
Custom mRNA-based cell reprogramming service
Custom mRNA stability test service
One-stop mRNA therapeutics development
mRNA Products
Technologies & Supporting
02
03
04
05
10
14
21
30
35
42
43
Contents
3. About
Creative Biolabs
THE
BEST
VENDOR
FOR mRNA SURPPORTING
About
Creative Biolabs
Since our inception in 2004, our research and service capacity has expanded
to the entire new drug discovery and development pipeline. As global
biotechnology company, we have more than 200 talented and well-trained
scientists located in different continents working closely with partners from
the entire world to develop and produce medicines of tomorrow. To support
the genomics research, we have established state-of-the-art mRNA supporting
platforms to provide the highest quality products and excellent services for
users in the life sciences, clinical and drug development sectors. Our team
possesses extensive expertise and experience which is able to providing the
complete, innovative solutions and comprehensive portfolio of mRNA
products and services to support your research.
2
4. mRNA Services
As a blueprint for protein synthesis, messenger RNA (mRNA) is a large class of single-
stranded RNA molecules that transferring the genetic information from DNA to protein.
In mammalian, a typical mature mRNA contains the coding sequence (CDS), 5‘ cap
structure and 3’ polyA tail, which greatly enhance their stability. Based on the advanced
mRNA platform, Creative Biolabs is able to provide excellent service and support to a
wide range of genomics researchers in the market, including flexible mRNA synthesis
and modification, mRNA stability and delivery study, custom mRNA-based cell
reprogramming service and therapeutics development. We look forward to working
with worldwide clients and we will be the best partner.
1
Areas
of
Expertise
Our
Capabilities
3
5. Features of Our mRNA Services
• Extensive expertise and rich experiences in mRNA research
• Highest quality products and excellent customized services
• A series of stringent criteria and standardized operation protocol
• Complete and innovative solutions for mRNA supporting
• One-stop-shop service and faster delivery
• Best after-sale services & Cost-saving
Key
Platforms
mRNA
synthesis
mRNA
modification
mRNA
stability
mRNA
delivery
Therapeutics
development
mRNA-based cell
reprogramming
mRNA
Services
Platform
Areas of Expertise
Our Capabilities
4
6. Creative Biolabs is committed to providing custom mRNA synthesis services for our clients. In
order to support customer demands, we have developed chemical synthesis and in vitro
transcription (IVT) method to produce different lengths of RNA. We are able to recommend
suitable approach according to the needs of customers.
Chemical Synthesis
Nucleosides or single nucleotides were used as raw materials and the mRNA was produced by chemical
synthesis method. This is a quick and more economical method when the fragment you need is small (<140 bp).
In Vitro Transcription (IVT)
It is a synthesis bottleneck that the yield of chemically synthesized RNA decreases exponentially with
increasing length. If you need long fragments of mRNA, we recommend RNA transcript synthesis.
Compared with the chemical synthesis, plasmid-based template by in vitro transcription up to thousands
of bases is highly feasible. The DNA templates can be provided by our customers or we can offer a one-
stop-shop service from the ground up. Our RNA transcript synthesis using the RNA polymerase-based
transcription system is an alternative when long and/or modified capped mRNAs are required.
Purification & QC
1.1 Custom mRNA synthesis
Capping & Poly (A)
Purification
In vitro Transcription
Linearization
Plasmid Prep
Areas of Expertise
Our Capabilities
5
7. In Vitro Transcription (IVT)---Template Generation
Effective in vitro transcription starts with high-quality template. We provide different types of DNA templates for in vitro transcription, including the DNA
plasmid, PCR-product, synthetic short oligo and cDNA. The DNA templates can be designed and synthesized according to the sequence of interest.
DNA templates
PCR-product Synthetic short oligo
Plasmid
When large amounts of RNA are needed, it is better to use a cloned template (DNA plasmid) in order to generate enough template using
simple and economical techniques based on bacterial culture and plasmid extraction.
When small amounts are needed, PCR-products and short oligos are probably the most convenient due to the flexibility in design of
the template and the ease of its production.
6
8. Areas of Expertise
Our Capabilities
RNA polymerase-based transcription system
Our mRNA synthesis is based on the RNA polymerase-based transcription
system and we are able to provide the high quality RNA polymerase
products to catalyze the formation of RNA from a DNA template.
RNA Polymerase KD Description
T7 RNA Polymerase 99 KD Highly specific for the T7 phage promoters
T3 RNA Polymerase 99 KD Highly specific for the T3 phage promoters
SP6 RNA Polymerase 98.5 KD Highly specific for the SP6 phage promoter
E. coli RNA Polymerase / RNA synthesis from E. coli promoter
7
In Vitro Transcription (IVT)
9. In Vitro Transcription (IVT)---Capping
and tailing
Capping Tailing
The most important steps of pre-mRNA processing are the
addition of stabilizing and signaling factors at the 5′ and 3′
ends of the molecule. Capping and tailing can prevent
degradation and facilitate translation in eukaryotic cells.
Enzyme-based mRNA Capping is performed after in vitro transcription using
5 ́
-triphosphate RNA, GTP, and S-adenosyl-methionine (SAM).
Co-Transcriptional mRNA Capping uses an mRNA cap analog, such as
ARCA and anti-reverse cap analog.
Enzymatic polyadenylation : Poly(A) tails can be added after transcription
using Poly(A) polymerase and ATP.
Polyadenylation with Transcription Template: Poly(A) stretches in
transcription templates can be encoded in plasmid templates. Alternatively, a
poly(A) stretch can be added during PCR-based generation of transcription
templates.
8
10. In Vitro Transcription (IVT)---RNA Purification
After RNA synthesis by in vitro transcription, the purification of
RNA is essential before use. Our platform provide various
purification methods to remove the small molecule and enzyme
reaction components. We are also proud to offer a family of high
performance and easy to use RNA purification kit for all your
RNA workflows.
Phenol/chloroform
extraction and ethanol
precipitation
01
02
03
04
05
Gel purification
Lithium chloride
precipitation
Silica column-based
purification
Chromatography (HPLC)
Areas of Expertise
Our Capabilities
9
11. mRNA primer design and synthesis
ORF-specific primers
Common primers
Design and synthesize the primer for the gene of interest.
The complementary to nucleotide sequences that
are very common in a particular set of DNA
molecules and cloning vectors, which are able to
bind to a wide variety of DNA templates.
Quality control of mRNA product
CatLog Item Method
Identity
RNA Sequence Sequencing
Visual appearance Colorless solution
RNA Length Bioanalyzer
Content
RNA content UV Spectroscopy
pH pH meter
Osmolality /
Purity
Integrity Fragment Analyzer
Bioburden /
Endotoxins /
Proteins Nano Orange Assay
Plasmid DNA qPCR
Residual solvents /
Capping LCMS
dsRNA Slot Blot
Creative Biolabs not only provides mRNA fragments
synthesis with different lengths but also performs the
mRNA primer design and synthesis service for the
amplification of a particular RNA sequence. A series of
stringent criteria are applied to implement quality
control (QC) of mRNA products in order to guarantee
reliability. We are also able to conduct the custom QC
service to best fit your requirements and expedite your
mRNA research to clinical stage.
Areas
of
Expertise
Our
Capabilities
10
12. 1.2 Custom mRNA modification
The modifications of mRNA are able to increase the stability and translation efficiency
of transfected in vitro-transcribed RNA. Our platform provides mRNA 5‘ Capping,
3’ poly(A) tailing, UTRs and coding sequence modification service to meet
customer requirements.
mRNA mature structure
3′ Poly(A)
tailing
5′ Capping
3′ UTR
5′ UTR
ORF
Areas of Expertise
Our Capabilities
11
13. mRNA 5' Capping
ARCAs Cap
M-ARCAs Cap
S-ARCAs Cap
Fluorescent Cap
Fluorophosphate-containing Cap
6-Thioguanosine-containing Cap
Most eukaryotic cellular mRNAs are modified by the the addition of a 7-methylguanosine cap to the 5′
end of the growing transcript by a 5′-to-5′ phosphate linkage. The mRNA cap structure play an important
role in mRNA functional study.
Cap-1 (m7G(5')pppN1mpNp)
Cap-0 (m7G(5')pppN1pN2p)
Cap-2 (m7G(5')pppN1mpN2mp)
5' Cap
Prevents the rapid degradation of mRNA by exonucleases
Mediates binding to eIF4E
Promote translation by engaging critical translation factors to recruit ribosomes to mRNAs
Prevents innate immune sensing
5'UTR β-globin 5'-UTRs enhance translation efficiency
ORF Codon composition affects translation efficiency
3'UTR
α-globin 3'-UTRs stabilize mRNA
β-globin 3'-UTRs enhance translation efficiency
Adenylate-uridylate-rich elements in 3'-UTRs degrade mRNA and reduces protein expression
Poly (A) tail
Length influences protein expression
Prevents de-capping and mRNA degradation
Masking affects translation
Commonly used modification strategies
Areas of Expertise
Our Capabilities
12
14. Nucleotides modification
Pseudo-uridine 2-thiouridine
2-thiouridine Pseudo-uridine 5-Methylcytidine
N6-methyladenosine
Except for the modification of RNA structural units, We also offer fluorescent labelling, nucleotides and base
modification, such as rare bases, phosphorthioate, modified groups (e.g. Amino, Biotin, DIG, PHOS) and various spacers
modification. Our platform is able to provide custom mRNA modification to accelerate your downstream application.
5-methylcytidine N6-methyladenosine (m6A)
13
Areas of Expertise
Our Capabilities
15. 1.3 Custom delivery vehicle for mRNA
Currently, methods and vehicles for intracellular
delivery remain the major barrier to the broad
application of mRNA therapeutics. Based on
recent advances in biomaterials and delivery
strategies, creative biolabs has established
various mRNA-based delivery systems for protein
therapy, gene editing, and vaccination.
Areas
of
Expertise
Our
Capabilities
14
16. Strategies Used for mRNA Delivery
• Ionizable Lipids : ATX-100, LP-01, OF-02, Lipid 5
• Polymers: PEI, APE, CART, OM-PBAE
• Dendrimers: PAMAM or PAMAM-based dendrimers
• Cell-Penetrating Peptides: RALA, D-isomeric XP
• Other Materials: Zwitter-ionic amino lipids (ZALs)
• Cell vehicle: DC, T cell, HSPC
Naked RNA
Viral Vectors: Adeno-associated viruses, Alphaviruses, Picornaviruses, Flavivirus
Naked mRNA displays a short plasma half-life, is prone to ribonuclease degradation, and faces
difficulties in entering the cell.
Using viral vectors embodies crucial drawbacks associated with genome integration,
and possible host rejection (immunogenicity and cytotoxicity) among others, hence
provoking the need for non-viral vectors for mRNA delivery.
Non-viral vectors
Areas of Expertise
Our Capabilities
15
17. LNP delivery system
The most commonly used non-viral vector is based on lipids or lipid-like compounds, such as the synthetic liposomes or lipid nanoparticles (LNPs). The LNPs are composed of lipid(s),
emulsifier/surfactant(s), co-surfactant (optional), solvents/co-solvents (optional) and active pharmaceuticals. The LNPs delivery systems can be fabricated using
biodegradable/ biocompatible solid lipid or a combination of lipids. Creative biolabs can offer customize LNP design by varying lipid compositions, vesicle sizes, surface charges, etc.
We can also provide the liposome encapsulation with high encapsulation efficiency and perform the LNPs analysis and characterization to meet your mRNA downstream application.
Lipid Nanoparticles (LNPs)
Composition Function For example
Lipid(s)
The lipid(s) is the primary ingredient for lipid nanocarriers
that impact on stability, encapsulation of drugs and
controlled release pattern of lipid dispersion.
Biocompatible/biodegradable
lipid materials, including fatty
acids, Glycerides and Waxes.
Surfactants
Stabilizing agents (surfactants) have an essential role to
produce solid lipid colloidal system. They decrease the
interfacial tension between the lipophilic and hydrophilic
phases of the colloidal dispersion and simplify to develop
nanoparticles by achieving colloidal stability during the
nanoparticle preparation process.
Phosphatidylcholines,
Phospholipids
Solvents/co-solvents
Solvents/co-solvents are organic liquids that dissolve
pharmaceutical actives and/or lipids and/or surfactants,
resulting to get a solution.
Ethanol, Acetone, Chloroform etc.
Cryoprotectants
The cryoprotectants added in colloidal suspension before
freezing to protect from the freezing stress
(cryoprotectant) or drying stress (lyoprotectant). They
also protect particle aggregation and destabilization
upon storage.
Sugars like mannitol, Glucose,
Trehalose, Sucrose, etc.
Drug candidates Pharmaceutical actives
Ofloxacin, Valsartan, Saquinavir,
etc.
16
18. LNP delivery system
Selection of Lipid(s)
The selection criteria of lipids for lipid nanoparticles
• Partition coefficient is the main criteria reported for the selection of lipid carriers
• Compatibility between drug and lipid carriers.
• Melting point of the lipid carrier should be more than 45°C to minimize the stability problems.
• The HLB value of core materials should be less than 2. Since they are more lipophilic and have
more chances to form solid matrices over the hydrophilic materials.
• Lipid carrier should have the property to stabilize the incorporated drugs.
• Higher and lower crystalline lipid matrix will lead to drug expulsion and degradation.
• Drug encapsulation decreases with following order: super-cooled melt < α modification <
β’modification < β modification. If transition will occur in β form during storage, then drug
expulsion will be more prone.
• Thermodynamic stability and lipid packing density.
• The occlusive property for topical preparation depends on the level of the lipid crystallinity.
Areas of Expertise
Our Capabilities
17
19. LNP delivery system
Selection of Surfactant and Co-surfactant
The selection criteria of Surfactant and Co-surfactant for lipid nanoparticles
• Non-ionic surfactants are more hydrophobic and have a greater capacity to solubilize poorly soluble drugs.
• They are non-irritant/toxic to biological membranes.
• Several non-ionic surfactants influence the drug pharmacokinetics by regulating efflux pumps such as
Pglycoprotein and/or multi-drug resistance-associated proteins
Selection of Solvents/co-solvents
The selection criteria of Solvents/co-solvents for lipid nanoparticles
• Invasive and non-invasive route of administration.
• Hydrophilic-lipophilic balance value of the surfactant.
• Consequences of lipid modification and particle size.
• The role of gastrointestinal lipid instability and degradation.
Other considerations for LNPs
delivery
Drug candidates for LNPs
Structures of LNPs
Models for drug incorporation into LNPs
Delivery routes
Production Methodologies for LNPs
18
20. LNP delivery system
Surface Modification of LNPs
The ultimate goal of nanoparticle-based drug delivery is reaching
the target cell. Currently, several passive or active functionalization
approaches have been successfully applied to lipid nanoparticles
intended for targeting. A variety of ligands may be functionally
LNP-attached including various internalizable ligands, specific
targeted peptides, saccharide ligands, or therapeutic molecules
(e.g. antibodies or enzymes). Creative biolabs is able to provide
the custom surface modification of LNPs with the aim of improving
its therapeutic and targeting performance.
Surface functionalization of lipid nanoparticles
Peptides/Proteins
Antibodies
Transferrins
Saccharide ligands
PEGylation, hydrophilic molecules
Enzymes
Areas
of
Expertise
Our
Capabilities
19
The advantages of surface-modified lipid nanoparticles
• Enhanced dispersibility of colloids.
• Improvement of colloids circulation in blood for systemic use.
• Increase stability of LNPs in GIT fluids and accelerate epithelium transport of LNPs.
• Enhanced biocompatibility and reduced thrombogenicity of drug carrier.
• Reduce nonspecific distribution and target tissues or specific cells
21. LNP delivery system
Analysis and Characterization of LNP
Based on the deep understanding of LNP, our platform is able to
provide professional solutions for LNP delivery system preparation
and characterization. We can provide the comprehensive analysis
and characterization for LNP before and after encapsulation, such as
the size distribution, stability, Zeta potential, visual appearance,
entrapment efficiency, lamellarity and release rate, etc.
Characterization LNPs
Size distribution
Stability
Zeta potential
Visual appearance
Entrapment efficiency
Lamellarity and release rate
20
22. 1.4 Custom mRNA-based Cell Reprogramming Service
The emergence of the mRNA reprogramming system in 2010 took the stem cell
field by surprise. Among the “non-integrating” reprogramming systems, mRNA
reprogramming is the most unambiguously “footprint-free,” most productive,
and perhaps the best suited to clinical production of stem cells. At creative
biolabs, we are able to provide custom mRNA-based cell reprogramming service
for our global clients. Our one-stop services explore the RNA mediated cell
reprogramming to induce specific target cell generation.
Areas of Expertise
Our Capabilities
The features of mRNA-based
Cell Reprogramming
No integration to
the genome
Non-viral application
eliminates bio-
containment concerns
Fast reprogramming
kinetics
High reprogramming
efficiency
No screening required
to eliminate viral
remnants
Custom T cell reprogramming by mRNA
Non-viral application eliminates bio-containment concerns
Custom Natural killer cell reprogramming by mRNA
Custom iPS cell reprogramming by mRNA
Custom mRNA-modified Dendritic cell therapy development
01
02
03
04
05
21
23. T cells are one of the main components of the adaptive immune system and exert their actions by modulating the function of other immune cells and by affecting the behavior of endothelial
and parenchymal cells. T-cell therapy is a promising new cancer immunotherapy treatment that activates a patient‘s immune system to attack and destroy cancer cells. T cells made with mRNA
encoding chimeric antigen receptor (CAR) offer a safe alternative to those transduced with viral CARs by mitigating the side effects of constitutively active T cells. At Creative Biolabs, we can
provide custom mRNA-based T cell reprogramming service to correct for abnormal immune cells and support the T-cell therapy.
Custom T cell reprogramming by mRNA
mRNA encoding CAR T-cell therapy---Workflow
Generation of CAR constructs and mRNA
Purification of IVT mRNA
T-cell isolation & expansion
RNA electroporation
In vitro & in vivo studies
Gene expression analysis
Areas of Expertise
Our Capabilities
22
24. B cells are at the center of the adaptive humoral immune system and are responsible for producing and secreting a particular immunoglobulin. Transfection with mRNAs has been broadly used
for delivery of costimulatory molecules, cytokines and antigen to modulate antigen presentation and immune stimulation functions of B cells. The activated B cells have been shown to be a
potential substitute for dendritic cells (DC) as a vaccine adjuvant in immunotherapy. Creative Biolabs is able to provide custom mRNA-based B cell reprogramming service by co-transfection of
multiple mRNAs encoding immune stimulatory molecules and endow these cells with the ability to induce adaptive immune responses.
Custom B cell reprogramming by mRNA
Reprogramming B cells with mRNA---Workflow
mRNA selection
(costimulatory molecules, cytokines, antigen )
Purification of IVT mRNA
B-cell isolation & expansion
RNA electroporation
Gene expression analysis
Flow cytometry
Areas of Expertise
Our Capabilities
23
25. Natural killer (NK) cells are cytotoxic immune cells that play an important role in the defense against cancer. Genetic manipulation of NK cells to improve their persistence, tumor-targeting
capacity, and the ability to home to disease sites in vivo may further enhance the efficacy of NK cell-based cancer immunotherapy. At creative biolabs, we provide mRNA reprogramming as
an alternative method to genetically modify NK cells, with the potential to reprogram multiple NK cell properties that boost their antitumor function without incurring any major negative
effects on this cell population.
Custom NK cell reprogramming by mRNA
Page 7
Workflow
mRNA Production NK Cells Expansion NK Cells Transduction Efficacy Evaluation
Cytotoxicity Assay
NK Cells Migration Assay
NK Cells Degranulation Assay
Persistence
Tumor-targeting capacity
Electroporation (Commonly used)
Lipofection
Viral vectors
Isolation of NK cells
Culture and Expansion of NK Cells
Isolation of PBMC
Analysis of purity and phenotype
mRNA design
mRNA Synthesis
Areas of Expertise
Our Capabilities
24
26. mRNA-based reprogramming
Virus-based reprogramming
Plate mRNA
transfection Identify
& Selection Expand cells
Plate Virus
transduction Pick &
Transfer Cloning &
Selecting
Expand cells
Timeline of up to 25 weeks
Timeline of less than 9 weeks
V
S
mRNA transfection &
Reprogramming
Colony picking
Expand cells
Workflow
Traditional methods for iPS cell reprogramming is
mediated by the retrovirus transduction of the
reprogramming factors. The strategy has low
reprogramming efficiencies and may result in viral
integration into the genome. Creative Biolabs is able to
offer a non-integrating approach for iPS cell
reprogramming by the administration of synthetic
modified mRNA, which increases the iPSC
reprogramming efficiency without incurring genetic
change. In order to meet various requirements, our
platforms provide custom mRNA service and ready-to-
order synthetic modified mRNA proven to reprogram a
wide variety of human cell types.
Custom iPS cell reprogramming by
mRNA
Areas of Expertise
Our Capabilities
25
27. Custom mRNA-modified Dendritic cell therapy development
Dendritic cells (DCs) are antigen-presenting cells that take up and process antigens and present
them to T cells. mRNA is a versatile tool to program dendritic cells as it is a polyvalent molecule
with an attractive safety profile and high protein expression. In recent years, the strategy of using
mRNA to deliver the anti-tumor message has gained a lot of attention and the mRNA-modified
DCs has shown promising results in clinical trials. Equipped with a team of professional scientists,
Creative Biolabs is capable of providing specialized one-stop mRNA-modified dendritic cell
therapy service. We can accommodate the specific attributes of your project and provide flexible
and integrated solutions.
Areas of Expertise
Our Capabilities
26
28. The form of mRNA loaded in DCs
Tumor antigen encoding mRNA
mRNAs encoding immune regulatory proteins
e.g. costimulatory molecules (CD83), tumour necrosis factor
receptor superfamily member 4 (TNFRSF4) and 4-1BB ligand
(4-1BBL), mRNA-encoded adjuvants (CD70, CD40L,
constitutively active TLR4)
e.g. ovalbumin (OVA)-encoding mRNA, melanoma-associated
antigens-encoding mRNA
mRNA-encoded pro-inflammatory cytokines
e.g. IL-12, or trafficking-associated molecules
Our
one-stop
service
workflow
Tumor antigen identification & mRNA synthesis
Preparation of Tumor Antigen-loaded Mature Dendritic Cells
Generation and identification of activated Antigen-specific CTLs
Efficacy evaluation of activated cell sorting
Various methods have been devised to identify different groups of
tumor antigens, e.g. SEREX, Immunology Methods, in silico
Tumor antigen encoding mRNA synthesis
PBMC isolation
DCs transduction, e.g. Electroporation, Lipofection
Mature DCs preparation
Mononuclear cells preparation Cocultured with DCs
Staining & FACS
27
Custom mRNA-modified Dendritic
cell therapy development --- (Cont’d)
29. Custom mRNA-modified Dendritic cell therapy development --- (Cont’d)
mRNA-
modified DCs
Preparation of Tumor Antigen-loaded Mature Dendritic Cells (mDCs)
• Isolation and Cryopreservation of PBMCs
• Differentiation of Dendritic Cells from Monocytes
• Feeding of Dendritic Cells with IL-4 and GM-CSF
• Harvesting of Immature Dendritic Cells
• Maturation of Dendritic Cells: DCs can be stimulated to mature using different stimuli. The most common
maturation stimuli that has been used in clinical studies has been a cocktail of cytokines (IL-1 β, TNFα, IL-6)
and prostaglandin E2 (PGE2). More recently, the use of Toll-like receptor (TLR) agonists have gained
popularity.
• Loading of mDCs with tumor antigen: Electroporation, Lipofection
• Cryopreservation of Dendritic Cells
• Lot Release Testing, Each batch of DC product must be evaluated and meet specific lot release criteria
before use. Phenotyping of DCs and assessment of their functional activity
With the commitment of being your best mRNA-DCs development partner, Creative Biolabs has established
the utmost efficient integrated solutions to prepare Tumor Antigen-loaded Mature Dendritic Cells.
Areas of Expertise
Our Capabilities
28
30. Creative Biolabs also provides the
generation of activated antigen-specific
CTLs and the evaluation of effectiveness of
activated cell sorting. We have
comprehensive evaluate existing
technologies, optimized processing
conditions, and provided a high-quality
solution for mRNA-modified Dendritic cell
therapy development.
Custom mRNA-modified
Dendritic cell therapy
development --- (Cont’d)
01 Generation of activated
antigen-specific CTLs
Mononuclear cells preparation
Co-cultured with DCs
Identification of
antigen-specific CTLs
Cells staining & Flow cytometry analysis
Isolation of antigen-specific CTLs
Efficacy evaluation of
activated cell sorting
Stimulation of proliferation of activated CTLs
Evaluation of effectiveness of activated CTLs
Cytotoxicity assay
02
03
Areas of Expertise
Our Capabilities
29
31. 1.5 Custom mRNA Stability Assay Service
Currently, mRNA-based therapeutics are emerging as promising options in a broad variety of medical
indications. However, the conventional mRNA has strong immunogenicity as well as the limited
stability, which is an essential parameter for envisaged medical applications. The regulation of mRNA
stability is a key posttranscriptional event that can greatly affect the net level of mRNAs in cells.
Cis-acting elements and trans-acting factors governing mRNA half-life
The turnover rate or stability of mRNA in vivo is usually reported as the time required for degrading
50% of the existing mRNA molecules. Creative biolabs has established reliable, rigorous, and “user-
friendly” methods to assess mRNA stability, measure decay rate constant and calculate mRNA
half-life. We also have the capability to perform custom mRNA stability assay development to meet
your unique requirements. Several techniques such as in situ hybridization, northern blot analysis,
and qPCR are available to determine the mRNA half-life after transcription inhibition. In particular, the
qPCR allows sensitive and rapid measurement of half-lives of mRNAs across a broad range of
expression levels, including low abundant mRNAs.
t1∕2 = ln2 ∕ kdecay
Half-life of an mRNA (t1/2) is inversely proportional to its decay rate constant (kdecay)
Measuring mRNA Half-Life
Actinomycin D-based method
• c-fos serum-inducible promoter system
• Tet-off regulatory promoter system
Assay development
DRB-based method
General inhibition of transcription
Inducible promoters system
30
32. Frequently, mRNA stability is studied by direct measurements of decay rates of mRNAs, including kinetic labeling
techniques and the use of transcriptional inhibitors. Actinomycin D as a transcription inhibitor has been widely
used in mRNA stability assays to inhibit the synthesis of new mRNA, allowing the assessment of mRNA decay by
measuring mRNA abundance following transcription inhibition. Our platform is able to provide the actinomycin
D-based method to measure stability changes of mRNAs.
Actinomycin D-based method
01
Actinomycin D forms a very stable complex with DNA, preventing the unwinding of the DNA
double-helix, thus inhibiting the DNA-dependent RNA polymerase activity.
At low concentrations, Actinomycin D inhibits transcription without significantly affecting DNA
replication or protein synthesis.
The advantage of Actinomycin D assay is that it does not require the
construction and introduction of exogenous genes into cells
02
03
Areas of Expertise
Our Capabilities
31
33. More advanced techniques such as the use of inducible promoters to control
transient transcription have presented advantages over the potential cytotoxic
effects of Actinomycin D or other transcription inhibitors in the analysis of mRNA
decay. Creative Biolabs is able to provide the transcriptional pulsing methods
based on the c-fos serum-inducible promoter and the tetracycline-regulated
(Tet-off) promoter systems to better explain mechanisms of mRNA turnover in
mammalian cells.
c-fos serum-inducible promoter system
The c-fos serum-inducible promoter system mediates high‐level, inducible expression in
various mammalian cell lines and has been valuable for transcriptional pulsing, which is
able to be induced in response to serum addition quickly and transiently, thereby
providing a reliable and simple way of achieving a transient burst in transcription.
Plate
01
02
03
04
05
Transient
transfection
Serum starvation
Serum induction
RNA extraction
Workflow
06
Northern blot
or qPCR
Areas of Expertise
Our Capabilities
32
34. Tetracycline-regulated (Tet-off) promoter system
The c-fos promoter system has some limitations that
prevent it from being used as a more general approach. It
requires serum or growth factor induction of quiescent
cells to activate c-fos promoter and many transformed
cell lines cannot be readily forced to enter a quiescent
state by serum starvation. The developed Tetracycline-
regulated (Tet-off) promoter system provides an alternate
strategy that further broadens the application of the
transcriptional pulsing approach to study mRNA turnover
in mammalian cells. In this system, binding of the tTA to
the tetO sequences can be quickly blocked by
tetracycline, preventing the activation of the target
promoter. Creative Biolabs is able to help our clients
construct the tetracycline-regulated promoter system and
provide a variety of mammalian cell lines harboring the
tTA gene for the successful use of the transcriptional
pulsing approach with the Tet-off promoter to monitor
mRNA decay kinetics.
Several caveats are important for the success of transcriptional pulsing strategy
• The amount of transfected plasmid DNA coding for the reporter mRNA must be empirically optimized
with a positive control coding for an unstable message to avoid saturation of the decay machinery with
excess mRNA.
• The optimal amount of transfected DNA may vary when different transient transfection reagents or cells
are used and must be optimized empirically.
• It is crucial to select a stable tTA-expressing clone that gives the maximally induced expression level of
the reporter gene.
• To accurately determine deadenylation and decay kinetics, a robust, yet brief, transcription is necessary.
Thus, the resumption kinetics of transcription on the removal of tetracycline displayed by the selected
stable line is a crucial factor.
• Cells should be continually maintained in the presence of tetracycline, except for the short period of
induction, because production of tTA for a longer period seems cytotoxic to the cells, and cells that
have lost tTA expression may gradually take over the population during prolonged incubation without
tetracycline.
33
35. Assay Development
In addition to the general inhibition of transcription and two transcriptional pulsing
methods, Creative Biolabs is also able to provide the custom assay development to
measure mRNA half-life and stability. We also also provides guidelines to help
develop optimal protocols for studying mammalian mRNA turnover in different cell
types under a wide range of physiologic conditions. Based on the advanced
technology and powerful research & development team, our service can be designed
to meet your special needs. We are glad to share our valuable experience on the
study of mRNA stability and will work with you to design the program that best fits
your requirements and expedite your mRNA project to clinical trials.
Project Consultation Project Analysis Scheme Design Assay Validation Data Analysis Project Reports
How We Provide Assay Development Services to You
34
36. 1.6 One-stop mRNA therapeutics development
The mRNA therapeutics have become an attractive gene therapy strategy that holds many advantage, including
controllable synthesis, low immunogenicity, safety, rapid transient protein expression, effective in both mitotic
and non-mitotic cells, etc. With professional service and various technology platforms at Creative Biolabs, we
offer the one-stop mRNA therapeutics development service covering the immunotherapy, genetic diseases
therapy, protein replacement therapy, regenerative medicine, therapeutic antibody-coding mRNA
therapy, and mRNA pharmacology optimization. Academic researchers in biotechnology can carry out the
whole procession of mRNA therapeutics development.
Immunotherapy
Genetic Diseases
Protein Replacement
Regenerative Medicine
Therapeutic Antibody
Pharmacology Optimization
Our one-stop mRNA therapy
development services
Areas of Expertise
Our Capabilities
35
37. Immunotherapy
Immunotherapy uses substances made by the body or in a laboratory to improve or restore immune system function. Currently, mRNA has progressed into a promising new class of
medicine for immunotherapy, including the mRNA vaccine for active immunization and as a drug substance for delivery of recombinant proteins to transiently equip the body with
exogenously generated immunological effectors. As a frontier biotech service provider, Creative Biolabs is dedicated to provide one-stop mRNA therapeutics development service
for immunotherapy. We also offer custom antigen mRNA synthesis as well as mRNA expressing the classical antigen.
mRNA Vaccine for Active Immunotherapy
Non-replicating mRNA Vaccine
Two major types of mRNA vaccine have been utilized against infectious pathogens and cancer:
Self-amplifying or replicon RNA vaccines
RNA synthesized by in vitro transcription using a RNA polymerase and template DNA that
encodes the antigen of interest.
Most used self-amplifying mRNA (SAM) vaccines are based on the alphavirus, where the
genes encoding the RNA replication machinery are intact but the genes encoding the
structural proteins are replaced with the antigen of interest. It enables a large amount of
antigen production owing to intracellular replication of the antigen-encoding RNA.
mRNA for Passive Immunotherapy
For passive immunotherapy, mRNA prepared by in vitro transcription (IVT) is
increasingly appreciated as transient carrier of genetic information translated into
protein in the cytoplasm. As a drug substance for delivery of recombinant proteins,
therapeutic application of mRNA combines several advantages:
mRNA harbors inherent safety features
mRNA allows supplying proteins that are difficult to manufacture
mRNA offers extended pharmacokinetics for short-lived proteins
mRNA does not require a nuclear phase for activity
mRNA may prolong the availability of effector molecules
36
38. mRNA for Genetic Diseases
The mRNA is the key link in the process of translating genetic information
encoded in DNA into instructions that are used by cells to produce the proteins
needed to carry out essential cellular functions. Most genetic diseases are
caused by DNA mutation and result in the transcription of defective
instructions which further lead to the abnormal protein production. Creative
biolabs is able to provide the one-stop mRNA therapeutics development
service for various types of genetic diseases caused by protein or gene
dysfunction. We can help our clients design and synthetic mRNA encoding
natural, functional proteins that replace defective or missing proteins. Through
the successful production and administration of desired proteins, the mRNA
therapeutics is broadly applicable for the treatment of multiple diseases.
Advantages of mRNA for genetic diseases:
No potential risk of infection or insertional mutagenesis to restores gene expression
Enables the treatment of a wide range of rare and non-rare diseases
Half-life adjustable and drug-like properties
The protein synthesis can be controlled directly without intervening in the human genome
The mRNA does not need to enter the nucleus for translation
By introducing a specific mRNA, the physiological state of the cell is not altered
The introduced mRNA is translated by the cell’s own translational machinery
under physiological conditions.
37
39. mRNA for Protein Replacement Therapy
Protein replacement therapy is a method for treating
diseases and disorders via the supplement or replace
a protein in patients in whom that particular protein is
deficient or absent. Historically, different gene therapies
strategies based non-viral and viral vector approaches
have been used for protein replacement. However, these
methods have proved inefficient due to insertional
mutagenesis, a short half-life, a poor transduction
capacity and production of neutralizing antibodies. By
contrast, mRNA therapeutics as a protein replacement
tool with no risk of insertional mutagenesis are highly
promising for the treatment of various human disorders.
Creative Biolabs is a leading life science service provider
that has the capability to provide one-stop mRNA service
platform for protein replacement therapy. From the
foremost project design to the final data
interpretation, we implement strict inspections and
validations on each and every step.
Strategy Advantages Disadvantages
Recombinant Protein Fast delivery of paracrine factors Unstable and short half time
Protein levels can be controlled Unable to deliver intracellular proteins,
repetitive administration
Modified mRNA High and transient delivery, low
immunogenicity
Not usable for long-term expression of
protein
Stable and no genomic integration Unsuitable for genetic and chronic
conditions
Viral Vector High level of protein expression for
long-term
Genomic integration, uncontrolled protein
expression
Cell-specific gene expression Neutralizing antibody, side effects
Different Protein Replacement Strategies
38
40. One-stop
mRNA
Pharmacology
Optimization
mRNA Pharmacology Optimization
Creative biolabs is also able to provide mRNA
pharmacology optimization services for our global
customers. Based on the outstanding expertise and
rich experience, we offer a range of technologies to
improve the pharmacological aspects of mRNA,
including the structural modifications for tuning
mRNA pharmacokinetics, immunogenicity
modulation and effective mRNA delivery. Our
service can be designed to meet your special needs
if you have any requirements.
Structural modifications for tuning mRNA
pharmacokinetics
5’-Cap modification
5’ and 3’ UTR modification
Coding region modification
As an exogenous gene with immunostimulatory properties, mRNA may be beneficial or
harmful for treatment and we provides several strategies to modulate immunogenicity.
IVT mRNA purification Nucleosides modification Adjuvant Addition
Effective mRNA Delivery
Naked mRNA Viral Vector Non-viral Vector (LNP, DCs)
Poly (A) tail modification
Whole IVT mRNA process
Separation and purification
Immunogenicity Modulation
39
41. mRNA for Therapeutic Antibody Therapy
Page 7
The purified mRNA from in vitro transcription (IVT) has been widely used for the study of mRNA-based antibody
expression. Through the delivery of antibody coding mRNA to the target cells, the therapeutic protein is expressed by
the cells’ own translational machinery, and finally trigger the desired therapeutic effect. Creative Biolabs has established
the advanced mRNA platform for therapeutic antibody therapy and we can provide the design and synthetic of mRNA as
well as efficient assessments. Our experienced experts will help you design the program that best meet your purpose
and expedite your mRNA-based antibody therapy to clinical trials.
Antibody Formats
Selection of target-
specific antibody
• Protein
• Toxin & Tumor
• Bacterium & Virus
Design and
manufacturing of
antibody-encoding mRNA
• mRNA
Administration
and specific protein
expression
• Intrabodies
• Secreted scFvs & antibody
• CARs
Antibody-mediated
effect
• Target inactivation
• Opsonization & Inactivation
• Target killing
mRNA-Based Antibody Treatment Workflow
Areas of Expertise
Our Capabilities
40
42. mRNA for Regenerative Medicine
Page 7
The progress in mRNA technology has led to development of methods to control
cellular processes and precisely direct cellular reprogramming has revolutionized
regenerative medicine. The mRNA‐based method showed significantly higher efficacy
for reprogramming somatic cells to pluripotency compared with transitional
approach. Based on the advanced regenerative medicine platform, Creative Biolabs
is able to help our clients choose the most efficient and straightforward mRNA‐based
strategy and protocol for tissue engineering and regenerative medicine research. We
also provide multiple delivery methods for cell and organ‐specific targeting,
particularly the non-viral technologies for intracellular delivery.
mRNA Applications for
Regenerative Medicine
mRNA delivery for iPSC reprogramming
mRNA-directed cell differentiation and tissue regeneration
mRNA delivery to control stem cell secretome
mRNA applications for cytoprotection and angiogenesis
Cas mRNA delivery for xenotransplantation
41
43. As a remarkable servicer in the mRNA production,
Creative Biolabs also provide ready-to-use and high
quality products for your mRNA development. A series
of stringent criteria are applied to implement quality
control of mRNA-related products in order to
guarantee reliability. Our products focus on but not
limited to the following aspects.
Part of the products
CatLog mRNA-Related Products
Reagents for mRNA delivery Ionizable Lipids, Cationic Liposome, Polymers, Dendrimers
Cell-Penetrating Peptides (CPP), Protamine
Nucleofection reagents
Self-assembling polyplex nanomicelle
Nucleotide products for
mRNA research
Nucleosides, Nucleotides, Protective Nucleosides
Phospholipidides, Succinates, Dyes & Quenchers
Enzymes for mRNA research mRNA Polymerase
Rnase & Inhibitors
mRNA Ligase
mRNA Reverse transcriptase
mRNA Capping
mRNA Kits mRNA Isolation Kit
mRNA Purification Kit
ARCA-capped mRNA synthesis Kit
Others Genome editing mRNA
Reporter gene mRNA
Growth factor mRNA
mRNA Products 2
Areas
of
Expertise
Our
Capabilities
42
44. Taking advantage of the mRNA platform, Creative Biolabs is also able to provide custom
technologies & supporting service to meet your special needs if you have any
requirements. We can conduct many tests to evaluate the mRNA therapeutic efficacy and
have the capacity to satisfy our customers with timely and accurate compliance feedback.
We will apply the rigorous criteria that have been established for study design,
performance, monitoring and documentation as well in order to generate reliable and
solid data for every research projects. The techniques & supporting provided in our
platform includes but not limited to the following categories.
Technologies
Technologies & Supporting 3
Areas
of
Expertise
Our
Capabilities
TriMix Technology
LPR Technology
Supporting
Electroporation of mRNA
Nucleoporation of mRNA
PiggyBac Transposition system
Gene gun delivery of mRNA
43
45. THE BEST SOLUTIONS
FOR mRNA PRODUCTS & SERVICES
45-1 Ramsey Road Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356 Email: info@creative-biolabs.com
State-of-art Technology Platforms ·Available in Flexible
Scales ·High-quality & Customized Services ·Cost-saving
44